Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Chrysalis Ventures, established in 1993 by David Jones, operates from Louisville, Kentucky. The firm has a strong focus on technology-enabled businesses across various sectors, including healthcare, SaaS, fintech, energy, logistics, and media. Over its history, Chrysalis Ventures has deployed more than $500 million into its portfolio, which currently includes over 70 companies. The firm is recognized as one of the most established venture capital firms in the Midwest, leveraging its extensive experience to identify and support businesses with significant growth potential.
Chrysalis Ventures has evolved its investment strategy to emphasize early-stage and expansion-stage companies that demonstrate the ability to generate between $1 million and $10 million in EBITDA. The firm actively seeks to partner with proven operators in fragmented industries where technology can enhance operations and drive growth through strategic acquisitions. Their notable milestones include successful exits such as Appriss, Advanced Academics, and Tritel, showcasing their ability to identify and nurture high-potential companies.
Chrysalis Ventures primarily invests in established businesses that can generate between $1 million and $10 million in EBITDA. The firm targets early-stage and expansion-stage companies, particularly those already generating at least $1 million in revenue. Their investment strategy is centered on fragmented industries where technology can optimize operations and facilitate growth through acquisitions. This approach allows them to leverage their expertise in predictive analytics and workforce technologies to enhance the operational capabilities of their portfolio companies.
The firm focuses on several key sectors, including healthcare, SaaS, fintech, energy, logistics, and media. Chrysalis Ventures emphasizes partnering with talented management teams who have a proven track record in their respective markets. This collaborative approach aims to drive organic growth and strategic acquisitions, positioning their portfolio companies for long-term success in competitive landscapes.
Chrysalis Ventures has built a diverse portfolio of over 70 companies, showcasing its commitment to investing in technology-enabled businesses. Notable exits from their portfolio include:
In addition to these exits, Chrysalis Ventures continues to support a range of active portfolio companies across various sectors, reinforcing its strategy of investing in businesses with significant growth potential.
David A. Jones, Jr. - Founder. David has a background in healthcare and technology, having co-founded Humana. His extensive experience in venture capital and operational management informs the strategic direction of Chrysalis Ventures.
Charlie Crawford - Team Member. Charlie brings expertise in business services and technology investments, contributing to the firm's focus on operational optimization.
Irv Bailey - Team Member. Irv has a strong background in logistics and media investments, enhancing the firm's capabilities in these sectors.
Wright Steenrod - Team Member. Wright specializes in fintech and energy investments, adding depth to the firm's portfolio strategy.
To pitch to Chrysalis Ventures, founders should send an email to info@chrysalisventures.com. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, competitive landscape, and financial projections. The firm prefers detailed information that demonstrates the startup's growth potential and operational strategy.
Response times may vary, but founders can generally expect to hear back within a few weeks. Warm introductions are beneficial, but not strictly necessary for initial outreach.
As of March 2023, Chrysalis Ventures continues to expand its portfolio, focusing on technology-enabled businesses in the Midwest and Southeast regions of the United States. The firm remains active in seeking new investment opportunities that align with its strategy of partnering with proven operators in underserved markets.
Recent notable exits include the successful sale of Appriss to Bain Capital and Advanced Academics to Devry, highlighting the firm's ability to identify and nurture high-potential companies.
What are Chrysalis Ventures' investment criteria?
Chrysalis Ventures primarily invests in early-stage and expansion-stage companies that can generate between $1 million and $10 million in EBITDA. They focus on technology-enabled businesses across sectors such as healthcare, SaaS, fintech, energy, logistics, and media.
How can I apply or pitch to Chrysalis Ventures?
Founders can reach out to Chrysalis Ventures via email at info@chrysalisventures.com. It is advisable to provide a detailed pitch deck that outlines the business model, market opportunity, and financial projections.
What makes Chrysalis Ventures different from other VC firms?
Chrysalis Ventures emphasizes partnerships with proven operators in underserved markets, focusing on technology-driven growth and operational optimization. Their expertise in predictive analytics and workforce technologies sets them apart.
What is the geographic scope of Chrysalis Ventures?
The firm primarily invests in the Midwest and Southeast regions of the United States, targeting companies that are generating at least $1 million in revenue.
What is the typical check size for investments?
Chrysalis Ventures typically invests between $1 million and $10 million in their portfolio companies, aligning their financial support with the growth potential of the business.
What kind of post-investment involvement can portfolio companies expect?
Chrysalis Ventures actively collaborates with portfolio companies, providing operational support and leveraging their expertise to optimize growth strategies and enhance business performance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.